Morning Meal-Associated Priming of the Liver

早餐相关的肝脏启动

基本信息

  • 批准号:
    10341641
  • 负责人:
  • 金额:
    $ 57.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-24 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

The liver is near-unique among the body organs in its ability to extract glucose and store it as glycogen under postprandial conditions, as well as to maintain a substantial rate of glucose production under fasting or hypoglycemic conditions. Our previous work has clearly shown that a morning period of hyperinsulinemia enhances hepatic glucose uptake and glycogen storage during an afternoon hyperinsulinemic hyperglycemic clamp mimicking a second meal. The goal of our current proposal is to identify factors influencing meal responses that can be utilized in improving the care of those with insulin resistance and type 2 diabetes. Specifically, in Aim 1 we will determine which aspect of morning hyperinsulinemia (direct effects on the liver or indirect effects brought about by insulin’s impact on the brain and/or fat tissues) is the key element involved in enhancement of afternoon hepatic glucose uptake. Furthermore, in Aim 2 we will determine the importance of the route of insulin delivery (intraportal vs peripheral circulation) in the morning on the afternoon response. This question is highly relevant to the treatment of those with insulin-dependent diabetes since most of the currently available insulin therapy involves delivery by a peripheral route. In addition, we will determine what factor or factors in the afternoon response are most clearly impacted by morning hyperinsulinemia (Aim 3). We will utilize the conscious, chronically catheterized dog model which is near-unique in that it not only makes possible the delivery of glucose and insulin into the portal circulation, the usual route of entry for ingested nutrients and secreted insulin, but also permits sampling from the hepatic and portal veins to allow the assessment of the liver’s response to the treatments. Importantly, the canine model has been shown to display many physiologic responses very similar to those in the human. The innovative aspects of the proposed experiments include the fact that the model allows us to clearly separate factors that may impact the response to the initial and subsequent meals of the day and examine the effect of each factor individually. The proposed studies are highly significant because the knowledge gained through these experiments has great potential to contribute to the development of new therapeutic approaches, more accurately tailored to bring about normal nutrient disposition, for those with impaired glucose tolerance (prediabetes) and diabetes.
在人体器官中,肝脏在餐后条件下提取葡萄糖并将其作为糖原储存,以及在空腹或低血糖状态下保持大量葡萄糖生成的能力几乎是独一无二的。我们之前的工作已经清楚地表明,上午的高胰岛素血症会在下午的高胰岛素血症高血糖钳夹期间增强肝脏葡萄糖摄取和糖原储存,模拟第二餐。我们目前的目标是确定影响饮食反应的因素,这些因素可以用于改善胰岛素抵抗和2型糖尿病患者的护理。具体来说,在目的1中,我们将确定上午高胰岛素血症的哪个方面(对肝脏的直接影响或胰岛素对大脑和/或脂肪组织的间接影响)是参与下午肝糖摄取增强的关键因素。此外,在Aim 2中,我们将确定上午胰岛素输送途径(门静脉内与外周循环)对下午反应的重要性。这个问题与胰岛素依赖型糖尿病患者的治疗高度相关,因为目前大多数可用的胰岛素治疗都是通过外周途径给药。此外,我们将确定下午反应中哪些因素或哪些因素最明显地受到上午高胰岛素血症的影响(目的3)。我们将利用有意识的、长期插管的狗模型,它几乎是独一无二的,因为它不仅可以将葡萄糖和胰岛素输送到门静脉循环中,这是摄入营养物质和分泌胰岛素的通常途径,而且还可以从肝脏和门静脉中取样,以便评估肝脏对治疗的反应。重要的是,犬类模型显示出许多与人类非常相似的生理反应。提出的实验的创新之处包括这样一个事实,即该模型允许我们清楚地分离可能影响对一天中最初和随后的饭菜的反应的因素,并单独检查每个因素的影响。提出的研究非常重要,因为通过这些实验获得的知识有很大的潜力有助于开发新的治疗方法,更准确地为糖耐量受损(前驱糖尿病)和糖尿病患者带来正常的营养配置。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alan D Cherrington其他文献

Alan D Cherrington的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alan D Cherrington', 18)}}的其他基金

Morning Meal-Associated Priming of the Liver
早餐相关的肝脏启动
  • 批准号:
    10663371
  • 财政年份:
    2021
  • 资助金额:
    $ 57.64万
  • 项目类别:
Therapeutic Protein Engineering of Single-Chain Insulin Analogs
单链胰岛素类似物的治疗性蛋白质工程
  • 批准号:
    10227330
  • 财政年份:
    2018
  • 资助金额:
    $ 57.64万
  • 项目类别:
Therapeutic Protein Engineering of Single-Chain Insulin Analogs
单链胰岛素类似物的治疗性蛋白质工程
  • 批准号:
    10455764
  • 财政年份:
    2018
  • 资助金额:
    $ 57.64万
  • 项目类别:
Gluconeogenesis and Glycogenolysis - Role and Regulation
糖异生和糖原分解 - 作用和调节
  • 批准号:
    8001363
  • 财政年份:
    2009
  • 资助金额:
    $ 57.64万
  • 项目类别:
HORMONE ASSAY % ANALYTICA SERVICES CORE
激素%20测定%20%%20分析%20服务%20核心
  • 批准号:
    7284643
  • 财政年份:
    2007
  • 资助金额:
    $ 57.64万
  • 项目类别:
BIOARTIFICIAL ORGANS III--TISSUE/IMMUNOISOLATION/TRIALS
生物人工器官 III——组织/免疫隔离/试验
  • 批准号:
    6216320
  • 财政年份:
    2000
  • 资助金额:
    $ 57.64万
  • 项目类别:
PILOT STUDIES--DIABETES RESEARCH AND TRAINING CENTER
试点研究--糖尿病研究培训中心
  • 批准号:
    6414868
  • 财政年份:
    2000
  • 资助金额:
    $ 57.64万
  • 项目类别:
CORE--HORMONE ASSAY FACILITY
核心——激素检测设备
  • 批准号:
    6414870
  • 财政年份:
    2000
  • 资助金额:
    $ 57.64万
  • 项目类别:
CORE--HORMONE ASSAY FACILITY
核心——激素检测设备
  • 批准号:
    6301033
  • 财政年份:
    1999
  • 资助金额:
    $ 57.64万
  • 项目类别:
PILOT STUDIES--DIABETES RESEARCH AND TRAINING CENTER
试点研究--糖尿病研究培训中心
  • 批准号:
    6105099
  • 财政年份:
    1999
  • 资助金额:
    $ 57.64万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 57.64万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.64万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 57.64万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.64万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 57.64万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 57.64万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.64万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 57.64万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 57.64万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.64万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了